BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Elixir Pharmaceuticals 

One Kendall Square
Building 1000, Fifth Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-995-7000 Fax: 617-995-7050


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company, Novartis Corporation (NVS); Deal Could Exceed $500 Million, Completes $12M Equity Financing 5/19/2009 11:42:15 AM
Elixir Pharmaceuticals' Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates Significant Reductions in HbA1c (Blood Glucose) Levels Compared to Type 2 Diabetes Patients Not Well-Controlled on Metformin Alone 11/19/2008 8:58:40 AM
Elixir Pharmaceuticals to Present at the UBS Warburg Global Life Sciences Conference 9/18/2008 8:44:13 AM
Elixir Pharmaceuticals Announces Exclusive Sirtuin Intellectual Property License Agreement with Boston University School of Medicine 7/1/2008 11:36:32 AM
Elixir Pharmaceuticals Announces Ghrelin Agonist Data Presentation at the Endocrine Society Annual Meeting 6/18/2008 10:12:19 AM
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting 6/9/2008 10:32:56 AM
Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator 5/28/2008 8:48:45 AM
Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science 4/28/2008 8:51:02 AM
Elixir Pharmaceuticals Establishes National Diabetes Advisory Board 4/9/2008 9:08:32 AM
Elixir Pharmaceuticals Presents New Data on Ghrelin Inhibition at Keystone Meeting 2/22/2008 8:40:50 AM
1234